Page last updated: 2024-11-04

sevoflurane and Mast Cell Activation Disease

sevoflurane has been researched along with Mast Cell Activation Disease in 1 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Research Excerpts

ExcerptRelevanceReference
"Mastocytosis is a disorder with potential anaesthesia complications."5.31[Mastocytosis: general anesthesia with remifentanil and sevoflurane]. ( Auvray, L; Freysz, M; Letourneau, B, 2001)
"Mastocytosis is a disorder with potential anaesthesia complications."1.31[Mastocytosis: general anesthesia with remifentanil and sevoflurane]. ( Auvray, L; Freysz, M; Letourneau, B, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auvray, L1
Letourneau, B1
Freysz, M1

Other Studies

1 other study available for sevoflurane and Mast Cell Activation Disease

ArticleYear
[Mastocytosis: general anesthesia with remifentanil and sevoflurane].
    Annales francaises d'anesthesie et de reanimation, 2001, Volume: 20, Issue:7

    Topics: Adjuvants, Anesthesia; Anesthesia, General; Anesthetics, Inhalation; Female; Histamine Release; Huma

2001